Information  X 
Enter a valid email address

Ironveld PLC (IRON)

  Print   

Friday 27 November, 2020

Ironveld PLC

Posting of GM Circular

RNS Number : 8246G
Ironveld PLC
27 November 2020
 

Ironveld plc

Posting of GM Circular and Amendment to Directors' Settlement Shares

General Meeting

 

Ironveld plc ("Ironveld" of "the Company"), announces that it has today posted a Shareholder Circular in respect of the General Meeting to be held at 10.00 am at the offices of Kuit Steinart Levy LLP, 7th Floor, Blackfriars House, The Parsonage, Manchester M3 2JA on 14 December 2020.

 

The Shareholder Circular will shortly be available to view at www.ironveld.com .

 

Directors Settlement Shares

 

Following the announcement on 26 November 2020 the Board has engaged with its major shareholders in respect of the proposed capitalisation of accrued Director salary / fees.  The Board acknowledges that a substantial proportion of these salary / fees relate to periods when the Company's share price was higher than the proposed Placing Price and has therefore agreed that a settlement based on the volume weighted average price of the Company's shares during the periods in which salary / fees were deferred would be more appropriate.

This will result in the number of Director Settlement Shares being issued in satisfaction of the £780,900 of deferred fees decreasing from 260,299,999 to 52,774,570, at an effective issue price per share of 1.48 pence. Any deferred sums remaining due to Chief Executive Martin Eales and settled in equity at a later date will be similarly calculated.

The revised table of Directors' interests, conditional on approval of all resolutions at the General Meeting, will therefore be:

Director's name

No of Existing Ordinary Shares

% of Existing Share Capital

Salary Shares and Loan Settlement Shares

No of New Ordinary Shares (on Admission)

% of Enlarged Share Capital (on Admission)

Giles Clarke*

21,211,050

3.24%

8,538,231**

29,749,281

2.29

Nick Harrison*

17,210,310

2.63%

5,204,898

22,415,208

1.73

Peter Cox

259,161

0.04%

28,526,239

28,785,400

2.22

Vred von Ketelhodt

262,500

0.04%

13,838,534

14,101,034

1.09

 

*Giles Clarke and Nick Harrison are both beneficially interested in 10,062,470 Ordinary Shares held by Westleigh Investments Limited.

** including 3,333,333 New Ordinary Shares resulting from the conversion of Loan Facilities.

 

Each of them is a related party of the Company for the purposes of the AIM Rules by virtue of their status as Directors of the Company. Martin Eales, being the independent director for this purpose, considers, having consulted with the Company's nominated adviser, finnCap, that the terms of such conversion is fair and reasonable insofar as the Company's shareholders are concerned.

 

The maximum number of Transaction Shares that may therefore be issued decreases from 848,141,628 to 640,616,199.

 

Capitalised terms used in this announcement have the meanings given to them in the announcement of the conditional Placing on 26 November 2020.

 

 

**ENDS**

 

For further information, please contact:

Ironveld plc

Giles Clarke, Chairman

Martin Eales, Chief Executive Officer

 


c/o Blytheweigh

+44 20 7138 3204

 

finnCap (Nomad and Joint Broker)

Christopher Raggett / Charlie Beeson

 


+44 20 7220 0500

Turner Pope (Joint Broker)

Andrew Thacker

 


+44 20 3657 0050

Blytheweigh

Tim Blythe / Megan Ray


+44 20 7138 3204

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQDLFLBFLZFBV

a d v e r t i s e m e n t